2025 CACLP Highlights: What Made This Year Special

1.Global Innovation Showcase

Multi-country pavilions: Delegations from Europe, North America, and Asia (e.g., Korea’s IVD Association) highlighted regional advancements in precision medicine and point-of-care testing.

2.Focus on Emerging Markets

Animal Health Diagnostics: A dedicated forum addressed the booming demand for veterinary diagnostics, aligning with China’s pet care market growth (projected to reach $15B by 2025) .

3.Groundbreaking Product Launches

ST-1000 Microfluidic Thromboelastography: A Chinese-developed device achieving bedside coagulation analysis with closed-system safety, aligning with national priorities for medical equipment localization.

About BMC

At BioMarket Connect, we bridge global biotech innovation with China’s dynamic market—and vice versa. From market entry strategies to localized branding and cross-border campaigns, we transform challenges into opportunities.

Ready to unlock your biotech potential in China or beyond? Let’s connect!